LEADER 04928nam 2200649 a 450 001 9910438010903321 005 20200520144314.0 010 $a1-62703-408-0 024 7 $a10.1007/978-1-62703-408-1 035 $a(CKB)3280000000020542 035 $a(EBL)1317008 035 $a(SSID)ssj0000904302 035 $a(PQKBManifestationID)11943815 035 $a(PQKBTitleCode)TC0000904302 035 $a(PQKBWorkID)10922725 035 $a(PQKB)11031795 035 $a(DE-He213)978-1-62703-408-1 035 $a(MiAaPQ)EBC1317008 035 $a(PPN)17048906X 035 $a(EXLCZ)993280000000020542 100 $a20130606d2013 uy 0 101 0 $aeng 135 $aur|n|---||||| 181 $ctxt 182 $cc 183 $acr 200 00$aLymphoma $ediagnosis and treatment /$fAnas Younes, Bertrand Coiffier editors 205 $a1st ed. 2013. 210 $aNew York $cHumana Press$d2013 215 $a1 online resource (414 p.) 225 1 $aCurrent clinical oncology ;$vv. 43 300 $aDescription based upon print version of record. 311 $a1-62703-407-2 320 $aIncludes bibliographical references and index. 327 $aPreface; Contents; Contributors; 1: The World Health Organization Classification of Lymphoid Neoplasms; Introduction; Precursor Lymphoid Neoplasm; B-Lymphoblastic Leukemia /Lymphoma, NOS; T- L ymphoblastic Leukemia/Lymphoma; Mature B-Cell Neoplasms; Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (CLL/SLL); B-Cell Prolymphocytic Leukemia; Splenic Marginal Zone Lymphoma; Lymphoplasmacytic Lymphoma/Waldenstro?m Macroglobulinemia; Plasma Cell Neoplasms; Extranodal Marginal Zone Lymphoma of Mucosa-Associated Lymphoid Tissue (MALT Lymphoma); Nodal Marginal Zone B-Cell Lymphoma 327 $aFollicular LymphomaPrimary Cutaneous Follicle Center Lymphoma; Mantle Cell Lymphoma; Diffuse Large B-Cell Lymphoma, Not Otherwise Specified; T-Cell-/Histiocyte-Rich Large B-Cell Lymphoma; DLBCL with a Predominant Extranodal Location; Primary Mediastinal (Thymic) Large B-Cell Lymphoma; Intravascular Large B-Cell Lymphoma; Primary Cutaneous DLBCL, Leg Type; Large-Cell Lymphomas of Terminally Differentiated B Cells; ALK-Positive Large B-Cell Lymphoma; Plasmablastic Lymphoma; Primary Effusion Lymphoma; Burkitt Lymphoma 327 $aB-Cell Lymphoma, Unclassifiable, with Features Intermediate Between DLBCL and Burkitt LymphomaB-Cell Lymphoma, Unclassifiable, with Features Intermediate Between DLBCL and Classical Hodgkin Lymphoma; Mature NK-Cell/T-Cell Neoplasms; T-Cell Prolymphocytic Leukemia; Aggressive NK-Cell Leukemia; EBV+ T-Cell Lymphoproliferative Disorders of Childhood; Adult T-Cell Leukemia /Lymphoma (ATLL); Extranodal NK-/T-Cell Lymphoma, Nasal Type (ENK/TCL, NT); Enteropathy-Associated T-Cell Lymphoma (EATL); Hepatosplenic T-Cell Lymphoma (HSTL); Subcutaneous Panniculitis-Like T-Cell Lymphoma (SPTCL) 327 $aHodgkin's LymphomaFollicular Lymphoma (FL); Mantle Cell Lymphoma (MCL); Burkitt's Lymphoma (BL); High-Throughput Sequencing (HTS); Array-Based Comparative Genomic Hybridization (aCGH); Profiling of Noncoding RNA; Epigenetic Profiling; Proteomic Profiling; Metabolic Profiling; Conclusion; References; 3: Molecular Profiling of Peripheral T-Cell Lymphomas; Background; Gene Expression Profiling of Peripheral T-Cell Lymphoma; Histogenesis of PTCLs; Molecular Pathogenesis; Targeted Therapy; Tyrosine-Kinase Inhibitors; Histone Deacetylase Inhibitors; Antiangiogenetic Therapy; Monoclonal Antibodies 327 $aPrognostication 330 $aRecently, understanding the molecular pathogenesis of malignant lymphomas has led to improvement in the diagnostic precision and to the identification of a variety of molecular therapeutic targets. In addition, new drugs have been approved in the US and Europe, resulting in changes in the standard of care of several types of lymphoid malignancies. Comprehensive in scope and developed by a team of internationally renowned authors, Lymphoma: Diagnosis and Treatment provides a timely update on the most important advances in the biology, diagnosis, and therapy of lymphomas. As part of the Current Clinical Oncology series, Lymphoma: Diagnosis and Treatment will be of value to medical oncologists, hematologists, radiation oncologists, and all physicians involved in the care of patients with lymphoid malignancies. 410 0$aCurrent clinical oncology (Totowa, N.J.) ;$vv. 43. 606 $aLymphomas$xDiagnosis 606 $aLymphomas$xTreatment 615 0$aLymphomas$xDiagnosis. 615 0$aLymphomas$xTreatment. 676 $a616.99 676 $a616.99/446 676 $a616.99446 701 $aYounes$b Anas$01758942 701 $aCoiffier$b Bertrand$01758943 801 0$bMiAaPQ 801 1$bMiAaPQ 801 2$bMiAaPQ 906 $aBOOK 912 $a9910438010903321 996 $aLymphoma$94197281 997 $aUNINA